Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01608672 · ClinicalTrials.gov registry record
Long-Term Patient Satisfaction of Facial Aesthetic Treatment With BOTOX®
A clinical trial, sponsored by Allergan.
- Completed
- Registry status
- 207
- Enrollment target
NCT01608672 is a clinical trial that has completed, run by Allergan. The registered enrollment target is 207 participants.
The verdict
NCT01608672 has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- 207 participants
- Enrollment target
Study Summary
This is an observational study assessing patient satisfaction following at least 5 years of BOTOX® treatment for glabellar lines.
Interventions
- BIOLOGICAL botulinum toxin Type A
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 207 participants |
| Start Date | 2012-04-01 |
| Est. Completion | 2012-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01608672
The ClinicalTrials.gov registry entry for NCT01608672 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 207 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Allergan, which has 314 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which botulinum toxin Type A is the first listed.
NCT01608672 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01608672 about?
NCT01608672 is a clinical study titled "Long-Term Patient Satisfaction of Facial Aesthetic Treatment With BOTOX®". This is an observational study assessing patient satisfaction following at least 5 years of BOTOX® treatment for glabellar lines.
What is the current status of trial NCT01608672?
This trial is currently completed. The enrollment target is 207 participants. The study started on 2012-04-01. Estimated completion is 2012-12-31.
What interventions are being tested in trial NCT01608672?
The interventions under investigation include: botulinum toxin Type A (BIOLOGICAL).
Who is sponsoring clinical trial NCT01608672?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.